OpenEvidence vs Treeline Biosciences
Which Medical AI tool is better in 2026?
OpenEvidence
AI medical assistant for clinicians
Treeline Biosciences
Computational and experimental drug discovery for hard-to-drug cancer targets
Side-by-side
Treeline Biosciences is the more established option (raised $1.1B); pricing is comparable on both sides.
| Metric | OpenEvidence | Treeline Biosciences |
|---|---|---|
| Taglinei | AI medical assistant for clinicians | Computational and experimental drug discovery for hard-to-drug cancer targets |
| Foundedi | 2022 | 2021🏆 |
| HQi | San Francisco, US | Stamford, US |
| Employeesi | 50-200🏆 | 201-500 |
| Neuron scorei | 64 | 82🏆 |
| Total fundingi | $735M | $1.1B🏆 |
| Latest roundi | Series D · Jan 2026 | Series A · Aug 2025 |
| Valuationi | $12B🏆 | — |
| Cheapest paid plani | — | Pricing not disclosed |
| Free plani | ✓ Free for Verified US Physicians | ✗ |
| Free triali | ✗ | ✗ |
| Top tier pricei | — | Pricing not disclosed |
| Pricing summaryi | 1 published plans | Enterprise · Contact sales |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for OpenEvidence and Treeline Biosciences.
| Capability | OpenEvidence | Treeline Biosciences |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✓ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | 2 (TypeScript, Python) | — |
| Free plan | ✓ | ✗ |
| Free trial | ✗ | ✗ |
| Verified | ✓ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of OpenEvidence
- Offers a free plan
- Newer company (2022)
- Verified profile
🔵 Strengths of Treeline Biosciences
- Has raised more capital ($1.1B vs $735M)
- Higher Neuron score (82 vs 64)
- More mature (2021)
Which should you choose?
Choose Treeline Biosciences if price matters most — it starts at Enterprise · Contact sales, which is friendlier for teams watching burn. Both AI Medical tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Treeline Biosciences if you want the most established option — it has raised $1.1B, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
OpenEvidence vs Treeline Biosciences — which is better?
It depends on your priority. OpenEvidence is the leaner option; Treeline Biosciences has broader feature depth. See the side-by-side table above.
Is OpenEvidence cheaper than Treeline Biosciences?
No — Treeline Biosciences's cheapest paid plan is Enterprise · Contact sales, while OpenEvidence's is Free.
Do OpenEvidence and Treeline Biosciences offer free plans?
OpenEvidence: Yes, has a free plan. Treeline Biosciences: Paid only.
Explore more AI Medical tools
Contextual paths to related AI startups, deals and rankings.